mHSPC
Onco
Daily
Twitter
Facebook
Youtube
RSS Feed
Linkedin
Facebook
RSS
Twitter
Youtube
Linkedin
June, 2024
June 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
« May
mHSPC
Jun 24, 2024, 01:48 |
Insight
Novel PARP inhibitor saruparib in metastatic hormone-sensitive prostate cancer
UroToday shared a post on X: . "The EvoPAR-Prostate 01 Trial:…
Jun 9, 2024, 13:12 |
Insight
ASCO24 Abstracts of High Interest by ECOG-ACRIN
During the 2024 American Society for Clinical Oncology (ASCO) Annual Meeting ECOG-ACRIN presented the following…
Apr 29, 2024, 22:41 |
Blog
Rana McKay: Critical Paper Validates Surrogacy of cPFS and rPFS in mHSPC
Rana McKay, Associate Professor of Medicine at UC San Diego, shared on their X/Twitter: ''Very important…
Apr 14, 2024, 14:15 |
Insight
Neeraj Agarwal: Data from SWOG 1216 trial in mHSPC
Neeraj Agarwal shared on X/Twitter: "Just in: Data from SWOG Cancer Research Network 1216 trial…
All:
4
Posts:
1 - 10
Eliot Levitt: The Yvonne Awards demonstrate something that it doesn't hurt to be reminded of
New data from the NEST clinical trial was presented at ESMOGI24 - Agenus
Zainab Shinkafi-Bagudu's latest commentary on Cervical Cancer Elimination Forum
New Paper Alert! Amivantamab-Lazertinib Improves Outcomes in High-Risk EGFR-Mutant NSCLC Subgroups: MARIPOSA Study Results
Learn more about overcoming barriers to immunotherapy for microsatellite stable colorectal cancer
Facebook
RSS Feed
Twitter
Linkedin
Youtube